Category:Statins
Jump to navigation
Jump to search
class of drugs used to lower cholesterol levels  | |||||
| Upload media | |||||
| Instance of |
| ||||
|---|---|---|---|---|---|
| Subclass of |
| ||||
| Part of |
| ||||
| |||||
 | |||||
Library of Congress authority ID: Subcategories
This category has the following 9 subcategories, out of 9 total.
A
- Atorvastatin (28 F)
C
- Cerivastatin (11 F)
F
- Fluvastatin (8 F)
L
- Lovastatin (21 F)
M
- Mevastatin (9 F)
P
- Pitavastatin (10 F)
- Pravastatin (7 F)
R
S
- Simvastatin (41 F)
Media in category "Statins"
The following 64 files are in this category, out of 64 total.
4.statinscompounds.png 301 × 301; 41 KB
4HMG-CoA.reductase.inhibitors.jpg 485 × 461; 44 KB
4statindiagrams.jpg 467 × 445; 49 KB
4Statins.png 516 × 443; 37 KB
4statinschemical.jpg 467 × 445; 48 KB
Advlip.jpg 911 × 615; 51 KB
Algorithm for statin-associated myopathy.jpg 810 × 900; 88 KB
Biosynthesis-dielsalder.png 1,523 × 1,602; 77 KB
Biosynthesis-lovd.png 1,442 × 1,177; 60 KB
ChemicalSTATINs.jpg 463 × 418; 45 KB
Cholesterolbiosynthesis.png 1,930 × 2,427; 40 KB
- Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s2.ogv 20 s, 1,344 × 1,024; 15.49 MB
- Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s3.ogv 20 s, 1,344 × 1,024; 12.31 MB
- Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s4.ogv 20 s, 1,344 × 1,024; 10.26 MB
- Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s5.ogv 19 s, 1,344 × 1,024; 18.75 MB
- Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s6.ogv 13 s, 1,344 × 1,024; 10.5 MB
- Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s8.ogv 13 s, 1,344 × 1,024; 10.57 MB
- Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s9.ogv 13 s, 1,344 × 1,024; 8.86 MB
Estatina final.png 315 × 209; 13 KB
Estatina.png 578 × 174; 17 KB
Fluvastatina Grupo fluorofenil.jpg 468 × 311; 26 KB
Four statins.png 516 × 443; 37 KB
Four.HMG-CoA.reductase.inhibitors.jpg 469 × 461; 43 KB
Fourstatincompounds.png 467 × 445; 31 KB
Metabolic pathway of a typical statin.png 4,762 × 4,757; 221 KB
Ogólny mechanizm plejotropowego działania statyn.png 3,507 × 2,480; 403 KB
Schematyczna budowa cząsteczki statyn.png 4,877 × 2,170; 109 KB
Simvastatin varieties.jpg 2,876 × 2,899; 2.37 MB
Statin diagrams.png 482 × 432; 35 KB
Statin final.svg 210 × 139; 14 KB
Statin mechanism v01.svg 652 × 282; 65 KB
Statin pharmacophore 2.png 3,787 × 2,861; 63 KB
Statin pharmacophore.png 665 × 614; 7 KB
Statin pharmacophore.svg 162 × 142; 10 KB
Statin Risks (6941350219).jpg 2,784 × 2,702; 1.08 MB
Statin-Test.png 838 × 759; 66 KB
Statin.structures.jpg 463 × 418; 46 KB
Statin.svg 385 × 116; 17 KB
Statinchart.png 516 × 461; 38 KB
Statincomparison.3.png 516 × 443; 38 KB
Statincomparison.png 516 × 443; 40 KB
Statincomparison2.png 516 × 443; 39 KB
Statincomparisonfinal.png 516 × 443; 39 KB
StatinCompounds.png 482 × 445; 33 KB
Statinfamily.2.png 568 × 539; 57 KB
Statinfamily.3.png 605 × 542; 48 KB
Statinfamily.png 1,144 × 315; 48 KB
Statinfamily213.png 534 × 461; 39 KB
Statinfamily55.png 580 × 539; 55 KB
Statinfamily902.png 534 × 477; 38 KB
StatinPathway WP430.png 828 × 743; 62 KB
Statins-1.generation v01.svg 988 × 476; 103 KB
Statins-2.generation v01.svg 912 × 1,150; 105 KB
Statins4compounds.png 305 × 301; 37 KB
Statins77.png 516 × 461; 38 KB
Wpływ fluwastatyny na wskaźniki lipidowe 01.png 1,747 × 1,900; 69 KB
Wpływ fluwastatyny na wskaźniki lipidowe 02.png 1,747 × 1,891; 46 KB
Wpływ fluwastatyny na wskaźniki lipidowe 03.png 1,751 × 1,900; 78 KB
Wpływ prawastatyny na wskaźniki lipidowe 01.png 1,747 × 1,900; 75 KB
Wpływ prawastatyny na wskaźniki lipidowe 02.png 1,747 × 1,891; 77 KB
Wpływ prawastatyny na wskaźniki lipidowe 03.png 1,755 × 1,900; 82 KB
.jpg)
